Picard Medical furnishes pre-recorded annual-meeting presentation

Picard Medical, Inc. furnished a press release and a pre-recorded presentation dated July 2, 2026 announcing the availability of a presentation in advance of its 2026 Annual Meeting of Stockholders, scheduled for July 17, 2026.

Accepted by SEC EDGAR 07/02/2026 - 08:15 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Picard Medical, Inc. furnished a press release and a pre-recorded presentation dated July 2, 2026 announcing the availability of a presentation in advance of its 2026 Annual Meeting of Stockholders, scheduled for July 17, 2026. The company filed the press release and presentation as Exhibit 99.1 and Exhibit 99.2 to this report.

Insights

Corporate Governance Analyst

Furnished meeting materials ahead of the annual meeting; routine disclosure.

The company made its pre-recorded presentation and press release available on July 2, 2026, ahead of the July 17, 2026 annual meeting. This is a standard governance practice to provide shareholders access to meeting materials.

Dependencies include whether the presentation contains any vote-request items or significant new disclosures; subsequent filings or the meeting itself will show any material actions taken.

Key Figures

Press release date: July 2, 2026 Annual meeting date: July 17, 2026 Exhibits furnished: Exhibit 99.1 and Exhibit 99.2 +2 more

5 metrics

Press release date July 2, 2026 date of press release and presentation

Annual meeting date July 17, 2026 2026 Annual Meeting of Stockholders scheduled date

Exhibits furnished Exhibit 99.1 and Exhibit 99.2 press release and presentation filed with Form 8-K

Trading symbol PMI Common Stock traded on The NYSE American, LLC

Commission File Number 001-42801 SEC Commission File Number on Form 8-K cover

Key Terms

pre-recorded presentation, Annual Meeting of Stockholders, Exhibit 99.1 / Exhibit 99.2

3 terms

pre-recorded presentation corporate

"announcing the availability of a pre-recorded presentation"

Annual Meeting of Stockholders corporate

"in advance of the Company's 2026 Annual Meeting of Stockholders"

Exhibit 99.1 / Exhibit 99.2 regulatory

"furnished as Exhibit 99.1 and Exhibit 99.2 and incorporated by reference"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): July 2, 2026

Picard Medical, Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-42801		86-3212894
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

1992 E Silverlake
Tucson, AZ 85713

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (520) 545-1234

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☒	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		PMI		The NYSE American, LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

8.01: Other Events

On July 2, 2026, Picard Medical, Inc. (the “Company”) issued a press release (the “Press Release”) announcing the availability of a pre-recorded presentation (the “Presentation”) in advance of the Company's 2026 Annual Meeting of Stockholders, scheduled for July 17, 2026. A copy of each of the Press Release and Presentation is furnished as Exhibit 99.1 and Exhibit 99.2 and incorporated by reference herein.

1

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are being filed herewith:

Exhibit No.		Description
99.1		Press Release, dated July 2, 2026
99.2		Presentation, dated July 2, 2026
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Picard Medical, Inc.
	By:	/s/ Richard Fang
		Name:	Richard Fang
		Title:	Interim Chief Executive Officer

Dated: July 2, 2026

3